1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Key Pharma News 17 NOVEMBER 2014

Key Pharma News 17 NOVEMBER 2014

  • November 2014
  • -
  • Espicom Business Intelligence
  • -
  • 29 pages

Industry Trend Analysis - Conference Reveals Future Diversification Of HCV Market
Industry Brief - Intarcia/Servier Sign Ex-US Partnership For ITCA 650 In Diabetes
Industry Brief - Genmab Transfers Ofatumumab Collaboration From GSK To Novartis
Industry Trend Analysis - Merck Places Confidence In Accurin Technology After Amgen's Exit
Industry Brief - BI/Lilly Revise Operational Structure Of Diabetes Alliance
Industry Brief - Pain Therapeutics To Regain Full Rights To Remoxy From Pfizer
Industry Trend Analysis - Oncology Will Be A Major Growth Driver For Amgen
Industry Trend Analysis - Sandoz Looks To Overturn Teva's Dominance
Industry Brief - Sanofi's Board Decides To Remove Viehbacher As CEO
Industry Trend Analysis - AstraZeneca Fast-Tracks Into Up-And-Coming LABA/LAMA Market
Industry Trend Analysis - BMS Interest Underlines Vitality Of Underserved IPF Market
Industry Trend Analysis - AstraZeneca Strengthens Immuno-Oncology Capabilities With Diagnostics Acquisition
Industry Brief - UCB To Sell Kremers To Private Equity Firms
Industry Trend Analysis - Dendreon Unlikely To Find Buyer With Provenge's Underperformance
Industry Trend Analysis - Ranbaxy Results Show Overall Strengthening As Sun Merger Approaches
Industry Brief - Eisai Neuroscience Business Officially Launched In Belgium And Luxembourg
Industry Trend Analysis - Branded Acquisitions Drive Actavis Forward, But Generics Remain Important
Industry Brief - FDA Accepts Boehringer's NDA For Additional Spiriva Respimat Indication
Industry Brief - FDA Approves Once-Daily Xigduo XR For Adults With Type II Diabetes
Industry Trend Analysis - Olysio's Additional FDA Approval Causes Little Change To Poor Sales Outlook
Industry Trend Analysis - FDA ODAC Vote Against MM Drug Is A Bad Start To Novartis' New Oncology Focus
Industry Trend Analysis - Avanir's Inhaled Migraine Therapy Will Not Be FDA-Approved In November
Industry Brief - GSK Files Regulatory Submissions For Mepolizumab In Severe Eosinophilic Asthma
Industry Trend Analysis - Eisai's Fycompa Will Remain Off German Market
Industry Brief - FDA Advisory Committee Recommends Edoxaban Approval In NVAF
Industry Brief - Gilead Seeks FDA Approval For TAF-Based Single-Tablet HIV Regimen
Industry Brief - FDA Approves Cyramza+Paclitaxel Combination for Advanced/Metastatic GC
Industry Brief - FDA Rescinds Ranbaxy Exclusivities Creating Opportunity For Dr Reddy's And Endo
Industry Trend Analysis - Jakavi's Myelofibrosis Monopoly Set To End
Industry Trend Analysis - Smoking Cessation: A Blockbuster Opportunity For Belviq
Industry Trend Analysis - Future Of Amgen's Trebananib In Question After Disappointing Overall Survival Results
Industry Brief - FDA Removes Full Clinical Hold On Imetelstat
Industry Trend Analysis - Brodalumab's Emerging Success In Plaque Psoriasis Heralds Competitive Edge

Table Of Contents

Key Pharma News 17 NOVEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.